RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
EpicentRx, Inc.
AbbVie
Roswell Park Cancer Institute
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey